PARTICIPATION OF PROSTAGLANDINS AND BRADYKININ IN THE EFFECTS OF ANGIOTENSIN-II AND CONVERTING ENZYME-INHIBITION ON SYMPATHETIC NEUROTRANSMISSION IN-VIVO
Jh. Schwieler et al., PARTICIPATION OF PROSTAGLANDINS AND BRADYKININ IN THE EFFECTS OF ANGIOTENSIN-II AND CONVERTING ENZYME-INHIBITION ON SYMPATHETIC NEUROTRANSMISSION IN-VIVO, Acta Physiologica Scandinavica, 152(1), 1994, pp. 83-91
We investigated the mechanism(s) by which angiotensin converting enzym
e (ACE)-inhibition and angiotensin (Ang) II influence peripheral sympa
thetic neurotransmission in canine gracilis muscle in situ, with alpha
-adrenoceptors either intact or irreversibly blocked by phenoxybenzami
ne. ACE-inhibition by ramiprilat reduced, and subsequent infusion of A
ng II (30 ng kg(-1) min(-1) i.v.) markedly increased arterial plasma A
ng-(1-8)octapeptide levels, basal muscle perfusion pressures and mean
arterial pressure. Local intra-arterial bolus injection of Ang II caus
ed marked vasoconstriction followed by vasodilation. This vasoconstric
tor response was enhanced and the ensuing vasodilation was abolished f
ollowing prostaglandin synthesis inhibition by diclofenac. The vasocon
strictor response to low frequency (0.5 Hz) sympathetic nerve stimulat
ion was also enhanced by diclofenac. The nerve stimulation-evoked nora
drenaline (NA) overflow was reduced by ramiprilat when alpha-adrenocep
tors were blocked (-11 +/- 3%, P < 0.05), but increased when alpha-adr
enoceptors were intact (+28 +/- 14%, P < 0.05). During ACE-inhibition,
effective bradykinin receptor antagonism by HOE 140 reduced stimulati
on-evoked NA overflow irrespective of alpha-adrenoceptor blockade (i.e
. by 25 +/- 5 and 20 +/- 3% in the absence and presence of alpha-adren
oceptor blockade, respectively, P < 0.01). Diclofenac increased stimul
ation-evoked NA overflow in the absence of alpha-adrenoceptor blockade
(+19 +/- 4%, P < 0.05). I.v. infusion of Ang II failed to enhance sti
mulation-evoked NA overflow both before and after diclofenac. In concl
usion, the results support the ideas that local formation of Ang II an
d bradykinin facilitate, and of prostaglandins inhibit NA release, and
that ACE inhibition influences sympathetic neurotransmission through
all of these mechanisms in skeletal muscle in situ; the net result dep
ends on the degree of prejunctional alpha-adrenergic feedback inhibiti
on. Circulating Ang II may enhance the local formation of vasodilatory
prostaglandins, but does not seem to modulate NA release even after p
rostaglandin synthesis inhibition in this model. Our data suggest that
circulating AngII may not reach the perivascular sympathetic nerves t
o a significant extent in skeletal muscle in vivo.